 Connection
Paul Bunn to Oligopeptides
This is a "connection" page, showing publications Paul Bunn has written about Oligopeptides.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.265 |
|
|
|
-
Chan DC, Gera L, Stewart JM, Helfrich B, Zhao TL, Feng WY, Chan KK, Covey JM, Bunn PA. Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents. Clin Cancer Res. 2002 May; 8(5):1280-7.
Score: 0.172
-
Stewart JM, Gera L, Chan DC, York EJ, Simkeviciene V, Bunn PA, Taraseviciene-Stewart L. Combination cancer chemotherapy with one compound: pluripotent bradykinin antagonists. Peptides. 2005 Aug; 26(8):1288-91.
Score: 0.054
-
Chan D, Gera L, Helfrich B, Helm K, Stewart J, Whalley E, Bunn P. Novel bradykinin antagonist dimers for the treatment of human lung cancers. Immunopharmacology. 1996 Jun; 33(1-3):201-4.
Score: 0.028
-
Stewart JM, Gera L, Chan DC, Bunn PA, York EJ, Simkeviciene V, Helfrich B. Bradykinin-related compounds as new drugs for cancer and inflammation. Can J Physiol Pharmacol. 2002 Apr; 80(4):275-80.
Score: 0.011
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|